Literature DB >> 21928050

Mean platelet volume predicting carotid atherosclerosis in atherothrombotic ischemic stroke.

J C Arévalo-Lorido1, J Carretero-Gómez, P Villar-Vaca.   

Abstract

BACKGROUND: Platelets are involved in atherosclerosis. Mean platelet volume (MPV) could be a marker of platelet activation. We aim to determine whether MPV levels were correlated with the presence of atherosclerotic disease in carotid arteries of patients with stroke.
METHODS: We recruited 215 patients with atherothrombotic stroke. All the participants underwent ultrasonographic evaluation of their extracranial carotid arteries. MPV was measured in automated hematology analysis system. The subjects were divided according to plaques and severity of carotid stenosis. Univariate and multivariate statistical analyses and a ROC curve to predict carotid stenosis were performed.
RESULTS: Univariate analysis showed a positive relationship between MPV and the degree of carotid atherosclerosis (p < 0.00007), and with carotid intima to media thickness (p < 0.00002). In ROC curve, a MPV cut-off of 11.25 fl was obtained for a sensibility of 70% and a specificity of 71% (p < 0.02). Multivariate analysis showed significant correlation with severity of carotid stenosis, when MPV was higher than 11.25 fl (OR: 2.9, p < 0.00007).
CONCLUSIONS: Our results indicate that an elevated MPV could be an easily measurable marker of severity of carotid stenosis in patients with atherothrombotic stroke.

Entities:  

Mesh:

Year:  2011        PMID: 21928050     DOI: 10.1007/s11845-011-0755-8

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  24 in total

1.  Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease.

Authors:  I A Jagroop; D P Mikhailidis
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

2.  Mean platelet volume as an indicator of platelet activation: methodological issues.

Authors:  I Anita Jagroop; Stavroula Tsiara; Dimitri P Mikhailidis
Journal:  Platelets       Date:  2003-08       Impact factor: 3.862

3.  Platelet P-selectin facilitates atherosclerotic lesion development.

Authors:  Peter C Burger; Denisa D Wagner
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

4.  Influence of platelet size on outcome after myocardial infarction.

Authors:  J F Martin; P M Bath; M L Burr
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

5.  Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study.

Authors:  J Willeit; S Kiechl; F Oberhollenzer; G Rungger; G Egger; E Bonora; M Mitterer; M Muggeo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

6.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

7.  Marker proteins of platelet activation in patients with cerebrovascular disease.

Authors:  M Fisher; P H Levine; A L Fullerton; A Forsberg; C P Duffy; J J Hoogasian; D A Drachman
Journal:  Arch Neurol       Date:  1982-11

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  [C-reactive protein and carotid intima-media thickness in atherothrombotic ischemic stroke].

Authors:  Jose Carlos Arévalo Lorido; Juana Carretero Gómez
Journal:  Med Clin (Barc)       Date:  2009-09-13       Impact factor: 1.725

10.  Relationship between intima-media thickness in the common carotid artery and atherosclerosis in the carotid bifurcation.

Authors:  S Rosfors; S Hallerstam; K Jensen-Urstad; M Zetterling; C Carlström
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

View more
  7 in total

1.  The effect of disease control on mean platelet volume and red blood cell distribution in patients with acromegaly.

Authors:  Rifki Ucler; Mehmet Aslan; Murat Atmaca; Murat Alay; Esra Nur Ademoglu; Zehra Candan; Ismail Gulsen
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Mean platelet volume is decreased in HIV-infected women.

Authors:  S Qadri; S Holman; J Dehovitz; H Crystal; H Minkoff; J M Lazar
Journal:  HIV Med       Date:  2013-06-05       Impact factor: 3.180

3.  Mean platelet volume predicts outcome in patients with asymptomatic carotid artery disease.

Authors:  Florian J Mayer; Matthias Hoke; Martin Schillinger; Erich Minar; Itziar Arbesú; Renate Koppensteiner; Christine Mannhalter
Journal:  Eur J Clin Invest       Date:  2013-10-26       Impact factor: 4.686

4.  Differences in platelet indices between healthy Han population and Tibetans in China.

Authors:  Qian Niu; Ruke Zhang; Min Zhao; Sugen Zeng; Xunbei Huang; Hong Jiang; Youfang An; Luwen Zhang
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Mean platelet volume: When the size does matter.

Authors:  José Carlos Arévalo-Lorido
Journal:  Anatol J Cardiol       Date:  2015-10       Impact factor: 1.596

6.  The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis.

Authors:  Jacek Staszewski; Aleksandra Pogoda; Kamila Data; Klaudia Walczak; Maciej Nowocień; Emilia Frankowska; Adam Stępień
Journal:  Clin Interv Aging       Date:  2019-02-27       Impact factor: 4.458

7.  Mean Platelet Volume, C-Reactive Protein, and Prognosis in Patients with Acute Ischemic Stroke Following Intravenous Thrombolytic Treatment.

Authors:  Yusuf İnanç; Semih Giray; Yılmaz İnanç
Journal:  Med Sci Monit       Date:  2018-06-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.